Teladoc Health, Inc. (0LDR.L)
- Previous Close
9.39 - Open
9.65 - Bid --
- Ask --
- Day's Range
9.65 - 9.68 - 52 Week Range
9.65 - 30.38 - Volume
440 - Avg. Volume
19,437 - Market Cap (intraday)
702.442M - Beta (5Y Monthly) 0.91
- PE Ratio (TTM)
-- - EPS (TTM)
-43.42 - Earnings Date Oct 22, 2024 - Oct 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
www.teladochealth.com4,816
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 0LDR.L
View MoreResearch Reports: 0LDR.L
View MorePerformance Overview: 0LDR.L
Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0LDR.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0LDR.L
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-38.54%
Return on Assets (ttm)
-3.42%
Return on Equity (ttm)
-52.96%
Revenue (ttm)
2.61B
Net Income Avi to Common (ttm)
-1.01B
Diluted EPS (ttm)
-43.42
Balance Sheet and Cash Flow
Total Cash (mrq)
1.16B
Total Debt/Equity (mrq)
105.78%
Levered Free Cash Flow (ttm)
274.05M